Loading...
  • clinical
  • We compare the Dynamic International Prognostic Scoring System (DIPSS), 2 developed for primary MF which is currently the most frequently used tool in clinical practice, with the post-polycythemia vera MF 3 risk stratification model, a model specific to secondary MF. (haematologica.org)
  • The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. (rochester.edu)
  • Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. (bioportfolio.com)
  • body
  • If we look at a patient of Polycythemia Vera from an ayurvedic point of view, his pitta body energy is exceptionally high as we know that blood and skin are predominantly governed by this bio - energy. (alwaysayurveda.net)